Bioworld
Published September 24, 2026
Kasvu's €30M series A to take novel antidepressant into the clinic - BioWorld
Read the full story at Bioworld
KTX-0141 does this without engaging the 5-HTA2 serotonin receptor that is responsible for the hallucinogenic effect of the psychedelics . Kasvu is.
Surfaced by 2 Google Alerts
- Psychedelics
- LSD